UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | Q | R | S | T | W | Y | Z
Number of items: 237.

A

Ancliff, PJ; Gale, RE; Liesner, R; Hann, I; Linch, DC; (2003) Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. BRIT J HAEMATOL , 120 (4) 685 - 690.

Ancliff, PJ; Gale, RE; Linch, DC; (2003) Neutrophil elastase mutations in congenital neutropenia. Hematology , 8 (3) pp. 165-171. 10.1080/1024533031000107497.

Ancliff, PJ; Gale, RE; Linch, DC; (2003) Neutrophil elastase mutations in congenital neutropenia. Hematology , 8 (3) pp. 165-171. 10.1080/1024533031000107497.

Ardeshna, K.M.; Smith, P.; Norton, A.; Hancock, B.W.; Hoskin, P.J.; MacLennan, K.A.; Marcus, R.E.; ... Linch, D.C.; + view all (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. The Lancet , 362 (9383) pp. 516-522. 10.1016/S0140-6736(03)14110-4.

Ardeshna, KM; Kakouros, N; Qian, WD; Powell, MG; Saini, N; D'Sa, S; Hoskin, PJ; ... Linch, DC; + view all (2003) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease in response to first line salvage chemotherapy regimens. In: BLOOD. (pp. 400A - 400A). AMER SOC HEMATOLOGY

Ardeshna, KM; Smith, P; Norton, A; Hancock, BW; Hoskin, PJ; MacLennan, KA; Marcus, RE; ... Brit Natl Lymphoma Invest, ; + view all (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. LANCET , 362 (9383) 516 - 522.

B

Bain, BJ; Gupta, R; (2003) A-Z of haematology. [Book]. Wiley-Blackwell

Baker, RJ; Gerrard, G; Wickremasinghe, RG; Hoffbrand, AV; Mehta, AB; Ross, DD; Ganeshaguru, K; (2003) Expression of breast cancer resistance protein in malignant cells from patients with leukaemia. In: LEUKEMIA. (pp. 662 - 662). NATURE PUBLISHING GROUP

Baldeschi, C; Gache, Y; Rattenholl, A; Bouillé, P; Danos, O; Ortonne, J-P; Bruckner-Tuderman, L; (2003) Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet , 12 (15) pp. 1897-1905. 10.1093/hmg/ddg200.

Benjamin, R; Davidoff, AM; Ng, CYC; Pizzey, A; Yong, K; Nathwani, AC; (2003) Murine models of hematological malignancies that mimic the disease phenotype in humans. In: BLOOD. (pp. 888A - 888A). AMER SOC HEMATOLOGY

Bennett, CL; Colledge, L; Richards, HE; Reay, PA; Blackburn, CC; Aebischer, T; (2003) Uncompromised generation of a specific H-2DM-dependent peptide-MHC class II complex from exogenous antigen in Leishmania mexicana-infected dendritic cells. EUROPEAN JOURNAL OF IMMUNOLOGY , 33 (12) pp. 3504-3513. 10.1002/eji.200323425.

Borthwick, NJ; Akbar, AA; Buckley, C; Pilling, D; Salmon, M; Jewell, AP; Yong, KL; (2003) Transendothelial migration confers a survival advantage to activated T lymphocytes: role of LFA-1/ICAM-1 interactions. CLIN EXP IMMUNOL , 134 (2) 246 - 252. 10.1046/j.1365-2249.2003.02298.x.

Bowen, DT; Frew, MEC; Hills, R; Gale, RE; Wheatley, K; Groves, MJ; Langabeer, SE; ... Linch, DC; + view all (2003) RAS gene mutation in acute myeloid leukemia; Analysis of cases from the medical research council AML 10 and 12 clinical trials. In: BLOOD. (pp. 374A - 375A). AMER SOC HEMATOLOGY

Bowles, L; Cohen, H; (2003) Inherited thrombophilias and anticoagulation in pregnancy. BEST PRACT RES CL OB , 17 (3) 471 - 489. 10.1053/S1521-6934(03)00012-9.

Brissault, B; Kichler, A; Guis, C; Leborgne, C; Danos, O; Cheradame, H; (2003) Synthesis of linear polyethylenimine derivatives for DNA transfection. Bioconjug Chem , 14 (3) pp. 581-587. 10.1021/bc0200529.

Brown, SA; Yee, TT; Griffioen, A; Lee, CA; (2003) Comparative study of full-length and B-domain deleted factor VIII concentrates. HAEMOPHILIA , 9 (6) 745 - 745.

Bucheit, AD; Kumar, S; Grote, DM; Lin, YK; von Messling, V; Cattaneo, RB; Fielding, AK; (2003) An oncolytic measles virus engineered to enter cells through the CD20 antigen. MOLECULAR THERAPY , 7 (1) pp. 62-72. 10.1016/S1525-0016(02)00033-3.

C

Camilleri, ; Cohen, H; (2003) Venous thromboembolism and the -455F/A b-fibrinogen polymorphism. In: (Proceedings) International society of thrombosis and haemostasis.

Camilleri, RS; Mackie, IJ; Humphries, SE; Machin, SJ; Cohen, H; (2003) Lack of association of beta 2-glycoprotein I polymorphisms Val247Leu and Trp316Ser with antiphospholipid antibodies in patients with thrombosis and pregnancy complications. BRIT J HAEMATOL , 120 (6) 1066 - 1072.

Chakrabarti, S; Mackinnon, S; (2003) The relevance of nonmyeloablative transplants in developing countries: Lessons from the UK experience. In: TRANSPLANTATION PROCEEDINGS. (pp. 172 - 173). ELSEVIER SCIENCE INC

Chakrabarti, S; Milligan, DW; Pillay, D; Mackinnon, S; Holder, K; Kaur, N; McDonald, D; ... Steven, N; + view all (2003) Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. BLOOD , 102 (3) 839 - 842.

Chantret, I; Dancourt, J; Dupré, T; Delenda, C; Bucher, S; Vuillaumier-Barrot, S; Ogier de Baulny, H; ... Moore, SEH; + view all (2003) A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation. J Biol Chem , 278 (11) pp. 9962-9971. 10.1074/jbc.M211950200. Gold open access

Chatterjee, R; Shah, F; Byers, MEAB; Sooranna, S; Bajoria, R; Pringle, JAS; Porter, JB; (2003) Prospective study of histomormometry, biochemical bone markers and bone densitometric response to pamidronate in beta-thalassaemia presenting with osteoporosis. In: BLOOD. (pp. 266A - 266A). AMER SOC HEMATOLOGY

Chelvatheebam, S; Langabeer, SE; Linch, DC; Hills, RK; Greenwell, P; (2003) Incidence and prognostic significance of C-MPL expression in acute myeloid leukemia. LEUKEMIA RES , 27 (9) 869 - 870. 10.1016/S0145-2126(03)00016-X.

Chen, FE; Dodi, AI; Travers, PJ; Madrigal, AJ; (2003) Age dependent differentiation status of virus specific CTL - Immunological implications of age as a risk factor in SCT. BLOOD , 102 (11) 2582-.

Clark, FJ; Piper, K; Gregg, R; Dunnion, D; Freeman, L; Mahendra, P; Craddock, C; ... Chakraverty, RK; + view all (2003) Characterisation of regulatory T-cells in patients with chronic graft-versus-host disease. In: (Proceedings) 45th Annual Meeting of the American-Society-of-Hematology. (pp. 408B-408B). AMER SOC HEMATOLOGY

Coeytaux, E; Coulaud, D; Le Cam, E; Danos, O; Kichler, A; (2003) The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J Biol Chem , 278 (20) pp. 18110-18116. 10.1074/jbc.M300248200. Gold open access

Cohen, H; (2003) How to stimulate active participation in haemovigilance. In: (Proceedings) European haemovigilance network.

Cohen, H; (2003) SHOT - the future. [Lecture]. Presented at: SHOT annual symposium, London.

Cohen, H; Stainsby, D; (2003) The 2001/2002 annual SHOT Report (on behalf of the serious hazards of transfusion steering group).

Cox, ST; McWhinnie, AJ; Robinson, J; Marsh, SGE; Parham, P; Madrigal, JA; Little, AM; (2003) Cloning and sequencing full-length HLA-B and -C genes. TISSUE ANTIGENS , 61 (1) pp. 20-48. 10.1034/j.1399-0039.2003.610103.x.

Cox, TM; Aerts, JM; Andria, G; Beck, M; Belmatoug, N; Bembi, B; Chertkoff, R; ... Zimran, AACTTEWGOGD; + view all (2003) The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. PMID: 14605497 , 26 (6) pp. 513-526.

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Selden, C; Sim, R; North, J; ... Dhillon, AP; + view all (2003) Hepatocyte progenitor cells in massive hepatic necrosis. In: JOURNAL OF PATHOLOGY. (pp. 2A - 2A). JOHN WILEY & SONS LTD

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Seldon, C; Sim, R; North, J; ... Dhillon, AP; + view all (2003) Hepatocyte progenitor cells in massive hepatic necrosis. JOURNAL OF HEPATOLOGY , 38 38 - 38.

Crowley, J; Hagan, R; Clancy, D; Rooney, G; Dunne, C; Lawlor, E; Hayden, P; ... Madrigal, JA; + view all (2003) Two sets of HLA Class II DRB and DQB1 alleles co-segregate among family members in a single maternal haplotype. Tissue Antigens , 61 (6) pp. 487-491.

D

D'Sa, S; Kyriakou, C; Bhattacharya, S; Peggs, K; Foulkes, B; Ings, S; Watts, M; ... Williams, C; + view all (2003) Etoposide, methylprednisolone, cytarabine and cisplatin (ESHAP) can cytoreduce resistant myeloma patients and mobilise them for transplant without adverse effects. In: BLOOD. (pp. 688A - 688A). AMER SOC HEMATOLOGY

D'Sa, S; Peggs, K; Pizzey, A; Verfuerth, S; Thuraisundaram, D; Watts, M; White, H; ... Yong, K; + view all (2003) T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions. British Journal of Haematology , 123 (2) pp. 309-322. 10.1046/j.1365-2141.2003.04612.x.

D'Sa, S; Peggs, K; Pizzey, A; Verfuerth, S; Thuraisundaram, D; Watts, M; White, H; ... Yong, K; + view all (2003) T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions. BRIT J HAEMATOL , 123 (2) 309 - 322.

Davidoff, AM; Ng, CY; Zhou, J; Spence, Y; Nathwani, AC; (2003) Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood , 102 (2) pp. 480-488. 10.1182/blood-2002-09-2889. Green open access
file

Davies, JK; Joh, MB; Prentice, HG; Lowdell, MW; (2003) Potentiating the MLR prior to selective depletion of alloreactive cells: investigating the use of pre-treatment of stimulatory T cells with OKT3. In:

Davies, JK; Koh, MB; Verfuerth, S; Mackinnon, S; Lowdell, MW; (2003) Selective depletion of CD69+ alloreactive donor T-cells by immunomagnetic sorting retains anti-viral activity, T-cell receptor V beta repertoire and functional T-regulatory cells within the donor cell pool. In: BLOOD. (pp. 965A - 965A). AMER SOC HEMATOLOGY

Davies, JK; Koh, MBC; Verfeurth, S; MACKINNON, S; Lowdell, MW; (2003) Selective depletion of CD69+ alloreactive donor T-cells by immunomagnetic sorting retains anti-viral activity, T-cell receptor V beta repertoire and functional T-regulatory cells. In: (pp. 965-).

Davies, JK; Lowdell, MW; (2003) New advances in acute graft-versus-host disease prophylaxis. TRANSFUSION MED , 13 (6) 387 - 397.

Davies, JK; Marden, C; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. BLOOD , 102 (11) 3542-.

Davies, JK; Marden, C; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. In: BLOOD. (pp. 951A - 951A). AMER SOC HEMATOLOGY

Davies, JK; Marden, CM; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - implications for development of an allogenic NK cell recipient conditioning approach. In: (pp. 951-).

Dehout, F; Schwarting, A; Beck, M; Mehta, A; Ricci, R; Widmer, UFOSI; (2003) Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data. Acta Paediatrica - Supplement , 92 (443) pp. 14-15.

Dogan, A; Attygalle, AD; Kyriakou, C; (2003) Angioimmunoblastic T-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY , 121 (5) pp. 681-691. 10.1046/j.1365-2141.2003.04335.x.

Douar, AM; Poulard, K; Danos, O; (2003) Deleterious effect of peptide insertions in a permissive site of the AAV2 capsid. Virology , 309 (2) pp. 203-208. 10.1016/s0042-6822(03)00186-7.

Duarte, RF; Morris, EC; Shaw, BE; Thomson, KJ; Ethell, M; Peggs, KS; Potter, MN; (2003) Recipient CMV seropositivity may adversely affect the outcome of unrelated donor transplantation by increasing the risk of disease relapse. In: BLOOD. (pp. 489A - 489A). AMER SOC HEMATOLOGY

Duke, VM; Gandini, D; Sherrington, PD; Lin, K; Heelan, B; Amlot, P; Mehta, AB; ... Foroni, L; + view all (2003) V-H gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica , 88 (11) 1259 - 1271. Green open access
file

de Groot, NG; Garcia, CA; Doxiadis, GGM; Marsh, SGE; Bontrop, RE; (2003) The "non-classical" MIC gene in chimpanzees shows reduced exon/intron variation as compared to humans. Genes and Immunity , 4 6-.

E

Eisman, S; Mehta, A; Orteu, CH; (2003) Case 3. Fabry disease. Clinical and Experimental Dermatology , 28 (5) pp. 569-570.

Enver, T; Brown, J; Bruno, L; Gale, K; Gupta, R; Heyworth, C; Hoffmann, R; ... Sarno, S; + view all (2003) Transcriptional programming and reprogramming in haematopoietic stem cells. In: (Proceedings) 13th Conference on Hemoglobin Switching. (pp. pp. 139-140). ACADEMIC PRESS INC ELSEVIER SCIENCE

F

Fallen, PR; Duarte, RF; McGreavey, L; Potter, M; Ethell, M; Prentice, HG; Madrigal, JA; (2003) Identification of non-naive CD4(+) CD45RA(+) T cell subsets in adult allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPL , 32 (6) 609 - 616. 10.1038/sj.bmt.1704185.

Fallen, PR; McGreavey, L; Madrigal, JA; Potter, M; Ethell, M; Prentice, HG; Guimaraes, A; (2003) Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPL , 32 (10) 1001 - 1014. 10.1038/sj.bmt.1704235.

Fields, PA; Cohen, H; Patterson, KG; (2003) Splenunculectomy in autoimmune thrombocytopenic purpura. Br J Haematol , 123 (3) 377-. 10.1046/j.1365-2141.2003.04351.x.

Folarin, NI; Baker, RJ; Lowdell, MW; Wickremasinghe, RG; Marks, AJ; Hoffbrand, AV; Mehra, AB; (2003) ZAP-70 detecting by flow cytometry in cells from chronic lymphocytic leukaemia patients using a highly fluorescent Alexa Flour dye. In: BLOOD. (pp. 347B - 348B). AMER SOC HEMATOLOGY

Folarin, NI; Baker, RJ; Lowdell, MW; Wickremasinghe, RG; Marks, AJ; Hoffbrand, AV; Mehta, AB; (2003) ZAP-70 detecting by flow cytometry in cells from chronic lymphocytic leukemia patients using a highly fluorescent Alexa Fluor dye. In: (pp. 5116-).

Foroni, L; Sorour, AF; Sinclair, PB; Duke, VM; (2003) Loss of heterozygosity (LOH) and microsatellite instability (MSI) of chromosome 6q16-21 identifies a prognostically poor group of childhood and adult T cell precursor acute lymphoblastic leukaemia (ALL) patients. BLOOD , 102 (11) 2236-.

Fricke, B; Argent, AC; Chetty, MC; Pizzey, AR; Turner, EJ; Ho, MM; Lolascon, A; ... Stewart, GW; + view all (2003) The "stomatin" gene and protein in overhydrated hereditary stomatocytosis. BLOOD , 102 (6) 2268 - 2277. 10.1182/blood-2002-06-1705.

Fricke, B; Stewart, GW; Treharne, KJ; Mehta, A; Knopfle, G; Friedrichs, N; Muller, KM; (2003) Stomatin immunoreactivity in ciliated cells of the human airway epithelium. ANAT EMBRYOL , 207 (1) 1 - 7. 10.1007/s00429-003-0324-7.

Frleta, D; Lin, JT; Quezada, SA; Wade, TK; Barth, RJ; Noelle, RJ; Wade, WF; (2003) Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice. J IMMUNOTHER , 26 (1) 72 - 84.

G

Gale, RE; (2003) Pathogenic markers in essential thrombocythemia. Curr Hematol Rep , 2 (3) pp. 242-247.

Gandini, D; Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2003) No mutations in the GATA-1 gene detected in patients with the acquired myeloproliferative disorder essential thrombocythaemia. In: BLOOD. (pp. 662A - 662A). AMER SOC HEMATOLOGY

Ganeshaguru, K; Jones, DT; Folarin, NI; Marks, AJ; Addison, E; North, JM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2003) Ansamycins synergize with conventional drugs in apoptotic killing of B-chronic lymphocytic leukaemia cells. In:

Ganeshaguru, K; Jones, DT; Folarin, NI; Marks, AJ; Addison, E; North, JM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2003) Ansamysins synergise with conventional drugs in apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. In: BLOOD. (pp. 349B - 349B). AMER SOC HEMATOLOGY

Garcia, CA; Robinson, J; Guethlein, LA; Parham, P; Madrigal, JA; Marsh, SGE; (2003) Human KIR sequences 2003. IMMUNOGENETICS , 55 (4) pp. 227-239. 10.1007/s00251-003-0572-y.

Garcia, CA; Robinson, J; Madrigal, JA; Marsh, SGE; (2003) Natural killer cell receptors: Functional roles. Inmunologia , 22 (2) pp. 190-202.

Gardiner, C; Pennaneac'h, C; Mackie, IJ; Sheldrake, A; Harrison, J; Machin, SJ; (2003) Falsely elevated D-dimer results in a healthy patient on account of heterophiletul antibodies. BRIT J HAEMATOL , 122 (5) 871 - 873.

Ginhoux, F; Doucet, C; Leboeuf, M; Lemonnier, FA; Danos, O; Davoust, J; Firat, H; (2003) Identification of an HLA-A*0201-restricted epitopic peptide from human dystrophin: application in duchenne muscular dystrophy gene therapy. Mol Ther , 8 (2) pp. 274-283. 10.1016/s1525-0016(03)00179-5.

Glassford, J; Soeiro, I; Koyasu, S; Lam, EWEA; (2003) BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Oncogene , 22 (15) pp. 2248-2259.

Grandage, VL; Linch, DC; Khwaja, A; (2003) P13Kinase is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NFkB, MAPKinase and P53 pathways. In: BLOOD. (pp. 585A - 585A). AMER SOC HEMATOLOGY

Gross, D-A; Leboeuf, M; Gjata, B; Danos, O; Davoust, J; (2003) CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection. Blood , 102 (13) pp. 4326-4328. 10.1182/blood-2003-05-1454.

Grote, D; Cattaneo, R; Fielding, AK; (2003) Neutrophils contribute to the measles virus-induced antitumor effect: Enhancement by granulocyte macrophage colony-stimulating factor expression. CANCER RES , 63 (19) 6463 - 6468.

H

Hajioff, D; Enever, Y; Quiney, R; Zuckerman, J; Mackermot, K; Mehta, A; (2003) Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy. J Inherit Metab Dis , 26 (8) pp. 787-794. 10.1023/B:BOLI.0000009948.86528.72.

Hajioff, D; Goodwin, S; Quiney, R; Zuckerman, J; MacDermot, KD; Mehta, A; (2003) Hearing improvement in patients with Fabry disease treated with agalsidase alfa. Acta Paediatr Suppl , 92 (443) pp. 28-30.

Harrison, CJ; Mazzullo, H; Cheung, KL; Gerrard, G; Jalali, GR; Mehta, A; Osier, DG; (2003) Cytogenetics of multiple myeloma: Interpretation of fluorescence in situ hybridization results. British Journal of Haematology , 120 (6) pp. 944-952. 10.1046/j.1365-2141.2003.04172.x.

Harrison, CJ; Mazzullo, H; Cheung, KL; Gerrard, G; Jalali, GR; Mehta, A; Osier, DG; (2003) Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results. BRIT J HAEMATOL , 120 (6) 944 - 952.

Hart, DP; Avivi, I; Thomson, KJ; Goldstone, AH; Linch, DC; Ell, PJ; Bomanji, JB; ... Mackinnon, S; + view all (2003) Use of Positron Emission Tomography following reduced intensity allograft for Hodgkin and Non Hodgkin Lymphoma to guide Donor Lymphocyte Infusion administration. In: BLOOD. (pp. 725A - 726A). AMER SOC HEMATOLOGY

Hart, DP; Thomson, KJ; Bannerjee, L; Morris, EC; Linch, DC; Goldstone, AH; Peggs, KS; (2003) Very low dose aciclovir prophylaxis post allogeneic stem cell transplantation prevents varicella zoster infection without development of clinically relevant resistance. In: BLOOD. (pp. 971A - 971A). AMER SOC HEMATOLOGY

Hernandez, D; Addou, S; Lee, D; Orengo, C; Shephard, EA; Phillips, IR; (2003) Trimethylaminuria and a human FMO3 mutation database. HUM MUTAT , 22 (3) 209 - 213. 10.1002/humu.10252.

Hewison, M; Freeman, L; Hughes, SV; Evans, KN; Bland, R; Eliopoulos, AG; Kilby, MD; ... Chakraverty, R; + view all (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J IMMUNOL , 170 (11) 5382 - 5390.

Horwood, E; Dowson, H; Gupta, R; Kaczmarski, R; Williamson, M; (2003) Myelofibrosis presenting as spinal cord compression. J Clin Pathol , 56 (2) pp. 154-156. 10.1136/jcp.56.2.154.

Hunter, HM; Peggs, K; Powles, R; Apperley, J; Mahendra, P; Cavenagh, J; Littlewood, T; ... Russell, NH; + view all (2003) A comparison of outcome for patients undergoing non-myeloablative stem cell transplantation compared to conventional conditioning for multiple myeloma. In: (pp. 2705-).

Hunter, HM; Peggs, K; Powles, R; Apperley, J; Mahendra, P; Cavenagh, J; Littlewood, T; ... Russell, NH; + view all (2003) A comparison of outcome for patients undergoing non-myeloablative stem cell transplantation compared to conventional conditioning for multiple myeloma. In: BLOOD. (pp. 732A - 732A). AMER SOC HEMATOLOGY

J

Jarvis, M; Marzolini, M; Wang, XN; Jackson, G; Sviland, L; Dickinson, AM; (2003) Heat shock protein 70: Correlation of expression with degree of graft-versus-host response and clinical graft-versus-host disease. TRANSPLANTATION , 76 (5) pp. 849-853. 10.1097/01.TP.0000083556.73555.78.

Jarvis, M; Marzolini, MAV; Wang, XN; Sviland, L; Dickinson, AM; (2003) Heat shock protein 70: Correlation of expression with degree of graft-versus-host response and clinical GVHD: Quantitative assessment using laser scanning confocal microscopy. In: (Proceedings) 17th European Histocompatability Conference/11th Annual Meeting of the German-Society-of-Immunogenetics. (pp. S47-S47). NATURE PUBLISHING GROUP

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; ... Wickremasinghe, RG; + view all (2003) Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. BLOOD , 101 (8) 3174 - 3180. 10.1182/blood-2002-07-2143.

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; ... Wickremasinghe, RG; + view all (2003) Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood , 101 (8) pp. 3174-3180. 10.1182/blood-2002-07-2143.

Jones, DT; Ganeshaguru, K; Mitchell, WA; Foroni, L; Baker, RJ; Prentice, HG; Mehta, AB; (2003) Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. BRIT J HAEMATOL , 121 (5) 713 - 720.

Jones, DT; Ganeshaguru, K; Mitchell, WA; Foroni, L; Baker, RJ; Prentice, HG; Mehta, AB; (2003) Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. Br J Haematol , 121 (5) pp. 713-720. 10.1046/j.1365-2141.2003.04340.x.

K

Kichler, A; Leborgne, C; März, J; Danos, O; Bechinger, B; (2003) Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc Natl Acad Sci U S A , 100 (4) pp. 1564-1568. 10.1073/pnas.0337677100.

Kichler, A; Sabourault, N; Décor, R; Leborgne, C; Schmutz, M; Valleix, A; Danos, O; ... Mioskowski, C; + view all (2003) Preparation and evaluation of a new class of gene transfer reagents: poly(-alkylaminosiloxanes). J Control Release , 93 (3) pp. 403-414.

Kottaridis, PD; Gale, RE; Linch, DC; (2003) FLT3 mutations and leukaemia. British Journal of Haematology , 122 (4) pp. 523-538. 10.1046/j.1365-2141.2003.04500.x.

Kottaridis, PD; Gale, RE; Linch, DC; (2003) FLT3 mutations and leukaemia. BRIT J HAEMATOL , 122 (4) 523 - 538.

Kottaridis, PD; Gale, RE; Linch, DC; (2003) Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia. Leukemia and Lymphoma , 44 (6) pp. 905-913. 10.1080/1042819031000067503.

Kottaridis, PD; Gale, RE; Linch, DC; (2003) Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia. LEUKEMIA LYMPHOMA , 44 (6) 905 - 913. 10.1080/1024819031000067503.

Krishnan, B; Ganeshaguru, K; Baker, R; Richfield, L; Mehta, AB; (2003) Multidrug resistance and myelomonocytic leukaemia in gaucher's disease. Haematologica , 88 (2) ECR02-. Green open access
file

Kroger, N; Thomson, K; Zabelina, T; Peggs, K; Chopra, R; Shimoni, A; Nagler, A; ... Mackinnon, S; + view all (2003) Comparison between anti-thymocyte globulin and alemtuzumab in melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with lymphoid malignancies. In: BLOOD. (pp. 484A - 484A). AMER SOC HEMATOLOGY

Kyriacou, C; Kottaridis, PD; Eliahoo, J; McKeag, N; Bomford, J; McGarrigle, HH; Linch, DC; ... Chatterjee, R; + view all (2003) Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies. Bone Marrow Transplantation , 31 (1) pp. 45-50. 10.1038/sj.bmt.1703777.

Kyriacou, C; Kottaridis, PD; Eliahoo, J; McKeag, N; Bomford, J; McGarrigle, HH; Linch, DC; ... Chatterjee, R; + view all (2003) Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies. Bone Marrow Transplantation , 31 (1) pp. 45-50.

Kyriacou, C; Kottaridis, PD; Eliahoo, J; Mckeag, N; Bomford, J; McGarrigle, HH; Linch, DC; ... Chatterjee, R; + view all (2003) Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies. BONE MARROW TRANSPL , 31 (1) 45 - 50. 10.1038/sj.bmt.1703777.

Kyriakou, CA; D'Sa, SP; Flory, A; Hanslip, J; Peggs, KS; Yong, KL; (2003) Cyclophosphamide, dexamethasone and thalidomide (CDT) is a well tolerated and effective regimen in advanced relapsed/refractory myeloma. In: (pp. 5270-).

Kyriakou, CA; D'Sa, SP; Flory, A; Hanslip, J; Peggs, KS; Yong, KL; (2003) Cyclophosphamide, dexamethasone and thalidomide (CDT) is a well tolerated and effective regimen in advanced relapsed/refractory myeloma. In: BLOOD. (pp. 386B - 386B). AMER SOC HEMATOLOGY

Kyriakou, CA; Yong, KL; Benjamin, R; Gandini, D; Davidoff, AM; Nathwani, AC; (2003) Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral mediated gene transfer inhibit growth of Burkitt's lymphoma in murine models. In: BLOOD. (pp. 744A - 744A). AMER SOC HEMATOLOGY

L

Laderach, D; Compagno, D; Danos, O; Vainchenker, W; Galy, A; (2003) RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells. J Immunol , 171 (4) pp. 1750-1757. 10.4049/jimmunol.171.4.1750.

Lawrie, AS; Gray, E; Leeming, D; Davidson, SJ; Purdy, G; Iampietro, R; Craig, S; ... Mackie, IJ; + view all (2003) A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique. BRIT J HAEMATOL , 123 (2) 335 - 341.

Love, EM; Jones, H; Williamson, LM; Cohen, H; (2003) SHOT – a voluntary system for the reporting of serious hazards of transfusion in the UK. Transfusion and transfusion alternatives , 5 pp. 248-255.

Lowdell, MW; (2003) Natural killer cells in haematopoietic stem cell transplantation. TRANSFUSION MED , 13 (6) 399 - 404.

Lowdell, MW; (2003) "Out damned spot": ex vivo purging revisited. BLOOD , 102 (12) 3860 - 3861.

Luong, QT; Hills, RK; Drayson, MT; Wheatley, K; Burnett, AK; Linch, DC; Bunce, CM; (2003) Expression of Nm23-H1 in AML correlates with white cell count at diagnosis and in vitro acts as a survival factor for primary AMLs cells; Evidence of a novel autocrine survival factor in AML. BLOOD , 102 (11) 2255-.

Luong, QT; Hills, RK; Drayson, MT; Wheatley, K; Burnett, AK; Linch, DC; Bunce, CM; (2003) Expression of Nm23-H1 in AML correlates with white cell count at diagnosis and in vitro acts as a survival factor for primary AMLs cells; Evidence of a novel autocrine survival factor in AML. In: BLOOD. (pp. 611A - 611A). AMER SOC HEMATOLOGY

M

Machin, SJ; (2003) Pros and cons of thrombophilia testing: cons. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 1 (3) pp. 412-413. 10.1046/j.1538-7836.2003.00168.x.

Mackie, IJ; Kitchen, S; Machin, SJ; Lowe, GDO; Brit Comm Stand Haematology, ; (2003) Guidelines on fibrinogen assays. BRIT J HAEMATOL , 121 (3) 396 - 404.

Madrigal, JA; Garcia, CA; Gutierrez, ME; Shaw, BE; Arguello, A; Jr, L; A M, M; (2003) El complejo mayor de histocompatibilidad y su papel biologico. HLA y su papel en la evolucion clinica de transplantes y enfermedades autoinmunes. In: Garcia-Conde, JJ and San Migual, JF and Sierra, J and Urbano-Ispizua, A and Vicente, V and Vives Corrons, JL, (eds.) Hematologia. (pp. 105-112). Aran Edcines: Madrid.

Maiers, M; Schreuder, GMT; Lau, M; Marsh, SGE; Fernandez-Vina, M; Noreen, H; Setterholm, M; (2003) Use of a neural network to assign serologic specificities to HLA-A, -B and -DRB1 allelic products. TISSUE ANTIGENS , 62 (1) pp. 21-47. 10.1034/j.1399-0039.2003.00097.x.

Marden, CM; North, J; Little, A; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. In: (pp. 964-).

Marden, CM; North, J; Little, AM; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. BLOOD , 102 (11) 3591-.

Marden, CM; North, J; Little, AM; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. In: BLOOD. (pp. 964A - 964A). AMER SOC HEMATOLOGY

Marks, AJ; Cooper, M; Orchard, K; Folarin, NI; Ganeshaguru, K; Hoffbrand, AV; Mehta, AB; (2003) Targeted therapy with an amphipathic peptide results in selective apoptotic cell death in CD19 positive chronic lymphocytic leukemia cells. BLOOD , 102 (11) 247-.

Marks, AJ; Cooper, M; Orchard, K; Folarin, NI; Ganeshaguru, K; Hoffbrand, AV; Mehta, AB; (2003) Targeted therapy with an amphipathic peptide results in selective apoptotic cell death in CD19 positive chronic lymphocytic leukemia cells. In: BLOOD. (pp. 73A - 74A). AMER SOC HEMATOLOGY

Marsh, SGE; (2003) HLA nomenclature and the IMGT/HLA sequence database. In: UNSPECIFIED (pp. 165-173).

Marsh, SGE; (2003) Nomenclature for factors of the HLA system, update June 2003. Hum Immunol , 64 (9) pp. 919-920.

Marsh, SGE; (2003) Nomenclature for factors of the HLA system, update May 2003. Hum Immunol , 64 (9) pp. 917-918.

Marsh, SGE; (2003) Nomenclature for factors of the HLA system, update September 2003. Eur J Immunogenet , 30 (6) 437-.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Hum Immunol , 64 (6) pp. 656-657.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Hum Immunol , 64 (6) 655-.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated August 2002. Hum Immunol , 64 (1) pp. 180-181.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated July 2002. Hum Immunol , 64 (1) 179-.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Witt, C; + view all (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. JOURNAL OF IMMUNOLOGICAL METHODS , 281 (1-2) pp. 1-8. 10.1016/j.jim.2003.08.001.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Wain, H; + view all (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. EUROPEAN JOURNAL OF IMMUNOGENETICS , 30 (3) pp. 229-234. 10.1046/j.1365-2370.2003.00383.x.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Wain, H; + view all (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. IMMUNOGENETICS , 55 (4) pp. 220-226. 10.1007/s00251-003-0571-z.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Wain, H; + view all (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. TISSUE ANTIGENS , 62 (1) pp. 79-86. 10.1034/j.1399-0039.2003.00072.x.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Wain, H; + view all (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. HUMAN IMMUNOLOGY , 64 (6) pp. 648-654. 10.1016/S0198-8859(03)00067-3.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Wain, H; + view all (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol , 64 (6) pp. 648-654.

Marsh, SGE; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Eur J Immunogenet , 30 (3) 237-.

Marsh, SGE; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Eur J Immunogenet , 30 (3) 235-.

Marsh, SGE; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update March 2003. Eur J Immunogenet , 30 (3) 239-.

Marsh, SGE; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Tissue Antigens , 62 (1) pp. 89-90.

Marsh, SGE; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Tissue Antigens , 62 (1) pp. 87-88.

Marsh, SGE; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update March 2003. Tissue Antigens , 62 (1) pp. 91-92.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update April 2003. Eur J Immunogenet , 30 (4) pp. 299-300.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update April 2003. Tissue Antigens , 62 (4) pp. 333-334.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update August 2002. Eur J Immunogenet , 30 (1) 91-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update December 2002. Tissue Antigens , 61 (5) pp. 412-413.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update December 2002. Eur J Immunogenet , 30 (2) 167-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update July 2002. Eur J Immunogenet , 30 (1) 89-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update June 2003. Eur J Immunogenet , 30 (4) pp. 303-304.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update June 2003. Tissue Antigens , 62 (4) pp. 337-338.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update May 2003. Tissue Antigens , 62 (4) pp. 335-336.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update May 2003. Eur J Immunogenet , 30 (4) 301-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update November 2002. Eur J Immunogenet , 30 (2) pp. 165-166.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update November 2002. Tissue Antigens , 61 (5) pp. 410-411.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update October 2002. Eur J Immunogenet , 30 (1) 95-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update October 2002. Tissue Antigens , 61 (5) pp. 408-409.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update September 2002. Eur J Immunogenet , 30 (1) pp. 93-94.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update, April 2003. Hum Immunol , 64 (8) pp. 835-836.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update, September 2002. Hum Immunol , 64 (5) pp. 572-573.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated August 2003. Hum Immunol , 64 (12) 1197-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated July 2003. Hum Immunol , 64 (12) pp. 1195-1196.

Martino, R; Giralt, S; Caballero, MD; Mackinnon, S; Corradini, P; Fernandez-Aviles, F; San Miguel, J; (2003) Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. HAEMATOLOGICA , 88 (5) 555 - 560. Gold open access

McCormick, AL; Benjamin, R; Pizzey, A; Kyriakou, C; Nathwani, AC; (2003) Facilitation of lentivirus mediated gene transfer into primary human and murine progenitors by Antp peptide. In: BLOOD. (pp. 995A - 995A). AMER SOC HEMATOLOGY

Mehta, A; (2003) Self-Assessment Colour Review of Clinical Haematology. [Book]. Manson Publishing

Mehta, A; (2003) The inner ear in Fabry disease. Acta Paediatrica , 92 p. 27.

Mehta, AB; Lewis, S; Laverey, C; (2003) Treatment of lysosomal storage disorders. BMJ (Clinical Research Ed.) , 30 (327) pp. 462-463.

Moon, JCC; Sachdev, B; Elkington, AG; McKenna, WJ; Mehta, A; Pennell, DJ; Leed, PJ; (2003) Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease - Evidence for a disease specific abnormality of the myocardial interstitium. EUR HEART J , 24 (23) 2151 - 2155. 10.1016/j.ehj.2003.09.017.

Morris, EC; Rebello, P; Thomson, KJ; Peggs, KS; Kyriakou, C; Goldstone, AH; Mackinnon, S; (2003) Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: Relevance for early adoptive immunotherapy and infectious complications. Blood , 102 (1) pp. 404-406. 10.1182/blood-2002-09-2687.

Morris, EC; Rebello, P; Thomson, KJ; Peggs, KS; Kyrialkou, C; Goldstone, AH; Mackinnon, S; (2003) Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications. BLOOD , 102 (1) 404 - 406.

Mumford, AD; McVey, JH; Morse, CV; Gomez, K; Steen, M; Norstrom, EA; Tuddenham, EGD; ... Bolton-Maggs, PHB; + view all (2003) Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C. Br J Haematol , 123 (3) pp. 496-501. 10.1046/j.1365-2141.2003.04624.x.

N

Nash, M; Camilleri, R; Liesner, R; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein 1 (anti-beta2GP1) polymorphism and antibodies to anti-beta2GP1. In: (Proceedings) International society of thrombosis and haemostasis.

Nash, MJ; Camilleri, RS; Liesner, R; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodies. BRIT J HAEMATOL , 120 (3) 529 - 531.

Nash, MJ; Camilleri, RS; Liesner, R; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (beta2GPI) polymorphism and anti-beta2GPI antibodies. British Journal of Haematology , 120 (3) pp. 529-531. 10.1046/j.1365-2141.2003.04130.x.

Nathwani, AC; Ng, CY; Zhou, JF; Spence, Y; Nienhuis, AW; Davidoff, AM; (2003) Liver targeted delivery of recombinant adeno-associated virus (rAAV) serotype 5 vectors leads to sustained therapeutic expression of human factor IX (hFIX) in non-human primates previously sensitized to rAAV2 vectors. In: BLOOD. (pp. 493A - 493A). AMER SOC HEMATOLOGY

Ng, CY; Karimipoor, M; Zhou, JF; Lajmi, A; Zhong, WY; Spence, Y; Davidoff, AM; (2003) Highly pure recombinant adeno-associated viral (rAAV) vectors based on serotype 8 generated by a simple scalable chromatography method efficiently transduce murine liver. In: BLOOD. (pp. 501B - 502B). AMER SOC HEMATOLOGY

O

Orleans-Lindsay, JK; Deru, A; Craig, JIO; Prentice, HG; Lowdell, MW; (2003) In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy. CLIN EXP IMMUNOL , 133 (3) 467 - 475.

Ouyang, Q; Wagner, WM; Wikby, A; Walter, S; Aubert, G; Dodi, A; Travers, P; (2003) Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. Journal of Clinical Immunology , 23 (4) pp. 247-257.

P

Pamphilon, DH; Lowdell, MW; (2003) Stem cells and immunotherapy. TRANSFUSION MED , 13 (6) 323 - 324.

Paston, SJ; Dodi, IA; Travers, PJ; Madrigal, JA; (2003) The role of HLA-B alleles in CMV peptide epitope presentation. Is there a hierarchy in HLA presentation of CMV epitopes: 14th Annual BSHI conference abstracts. European Journal of Immunogenetics , 30 (4) pp. 305-323.

Peggs, K; Mackinnon, S; (2003) Imatinib mesylate - The new gold standard for treatment of chronic myeloid leukemia. NEW ENGL J MED , 348 (11) 1048 - 1050.

Peggs, K.S.; Mackinnon, S.; Williams, C.D.; D'Sa, S.; Thuraisundaram, D.; Kyriakou, C.; Morris, E.C.; ... Yong, K.; + view all (2003) Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity. Biology of Blood and Marrow Transplantation , 9 (4) pp. 257-265. 10.1053/bbmt.2003.50009.

Peggs, K.S.; Thomson, K.; Hart, D.P.; Geary, J.; Morris, E.C.; Yong, K.; Goldstone, A.H.; ... Mackinnon, S.; + view all (2003) Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. Blood , 103 (4) pp. 1548-1556. 10.1182/blood-2003-05-1513. Green open access
file

Peggs, KS; Banerjee, L; Thomson, K; Mackinnon, S; (2003) Post-transplant lymphoproliferative disorders following reduced intensity conditioning with in vivo T cell depletion. BONE MARROW TRANSPL , 31 (8) 725 - 726. 10.1038/sj.bmt.1703893.

Peggs, KS; Mackinnon, S; Williams, CD; D'Sa, S; Thuraisundaram, D; Kyriakou, C; Morris, EC; ... Yong, K; + view all (2003) Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: Limited efficacy of graft-versus-tumor activity. BIOL BLOOD MARROW TR , 9 (4) 257 - 265. 10.1053/bbmt.2003.50009.

Peggs, KS; Thomson, K; Chopra, R; Mahendra, P; Milligan, D; Parker, A; Hunter, A; ... Mackinnon, S; + view all (2003) Long term results of reduced intensity transplantation in multiply relapsed and refractory Hodgkin's lymphoma: Evidence of a therapeutically relevant graft-versus-lymphoma effect. In: BLOOD. (pp. 198A - 199A). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; D'Sa, S; Yong, K; Mackinnon, S; (2003) Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantation. BRIT J HAEMATOL , 120 (1) 154 - 165.

Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Guiver, M; Moss, PA; Mackinnon, S; (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. LANCET , 362 (9393) 1375 - 1377.

Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Moss, P; Goldstone, AH; Yong, K; (2003) Reconstitution of T-cell repertoire after autologous stem cell transplantation: Influence of CD34 selection and cytomegalovirus infection. BIOL BLOOD MARROW TR , 9 (3) 198 - 205. 10.1053/bbmt.2003.50010.

Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Moss, P; Goldstone, AH; Yong, K; (2003) Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation , 9 (3) pp. 198-205. 10.1016/S1083-8791(03)70010-X.

Pepys, M.B.; Bybee, A.; Booth, D.R.; Bishop, M.T.; Will, R.G.; Little, A.-M; Prokupek, B.; (2003) MHC typing in variant Creutzfeldt-Jakob disease. The Lancet , 361 (9356) pp. 487-489. 10.1016/S0140-6736(03)12455-5.

Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; (2003) MHC typing in variant Creutzfeldt-Jakob disease. LANCET , 361 (9356) 487 - 489.

Porakishvili, N; Kulikova, N; Jewell, AP; Youinou, PY; Yong, K; Nathwani, A; Heelan, B; ... Lydyard, PM; + view all (2003) Preferential expression of CD180 by B cell chronic lymphocytic leukaemia (B-CLL) cells using IgVh mutated versus those using IgVh unmutated genes. In: (pp. S17-).

Porakishvili, N; Slovick, A; Jewell, AP; Youinou, PY; Nathwani, A; Yong, K; Stevenson, F; ... Lydyard, PM; + view all (2003) Activation of B-CLL cells by anti CD180 monoclonal antibodies: Responder and non-responder patients. In: BLOOD. (pp. 432A - 432A). AMER SOC HEMATOLOGY

Porter, JB; Waldmeier, F; Bruin, G; Shah, F; Hazell, K; Warrington, S; Delage, S; ... Schran, H; + view all (2003) Pharmacokinetics, metabolism and elimination of the iron chelator drug ICL670 in beta-thalassemia patients. In: BLOOD. (pp. 5B - 5B). AMER SOC HEMATOLOGY

Preiser, W; Brink, NS; Ayliffe, U; Peggs, KS; Mackinnon, S; Tedder, RS; Garson, JA; (2003) Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma. J CLIN VIROL , 26 (1) 49 - 59.

Q

Quezada, SA; Eckert, M; Adeyi, OA; Schned, AR; Noelle, RJ; Burns, CM; (2003) Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis. ARTHRITIS RHEUM , 48 (9) 2541 - 2554. 10.1002/art.11230.

Quezada, SA; Fuller, B; Jarvinen, LZ; Gonzalez, M; Blazar, BR; Rudensky, AY; Strom, TB; (2003) Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation. BLOOD , 102 (5) 1920 - 1926. 10.1182/blood-2003-02-0586.

R

Rai, R; Tuddenham, E; Backos, M; Jivraj, S; El'Gaddal, S; Choy, S; Cork, B; (2003) Thromboelastography, whole-blood haemostasis and recurrent miscarriage. HUMAN REPRODUCTION , 18 (12) pp. 2540-2543. 10.1093/humrep/deg494.

Reid, A.G.; Huntly, B.J.P.; Grace, C.; Green, A.R.; Nacheva, E.P.; (2003) Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia. British Journal of Haematology , 121 (3) pp. 419-427. 10.1046/j.1365-2141.2003.04291.x.

Rew, SB; Lopes, L; Koishihara, Y; Kosaka, M; Ozaki, S; Peggs, K; Chain, B; (2003) Potent anti-tumour cytotoxic T lymphocytes directed against the myeloma antigen HMI.24. In: BLOOD. (pp. 112A - 112A). AMER SOC HEMATOLOGY

Roberts, C; Robinson, J; Dodi, IS; Madrigal, JA; Marsh, SGE; (2003) The European Searchable Tumour Cell Line Database (ESTDAB). In: (pp. 321-).

Robinson, J; Marsh, SGE; (2003) HLA informatics. Accessing HLA sequences from sequence databases. In: UNSPECIFIED (pp. 3-21).

Robinson, J; Waller, M; Garcia, C; Stoehr, P; Marsh, SGE; (2003) IPD - The Immuno-Polymorphism Database. In: (pp. 322-).

Robinson, J; Waller, MJ; Parham, P; de Groot, N; Bontrop, R; Kennedy, LJ; Stoehr, P; (2003) IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. NUCLEIC ACIDS RESEARCH , 31 (1) pp. 311-314. 10.1093/nar/GKG070. Gold open access

Rotta, G; Edwards, EW; Sangaletti, S; Bennett, C; Ronzoni, S; Colombo, MP; Steinman, RM; ... Rescigno, M; + view all (2003) Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo. JOURNAL OF EXPERIMENTAL MEDICINE , 198 (8) pp. 1253-1263. 10.1084/jem.20030335.

S

Sen, S; Jalan, R; Morris, EC; Steiner, C; Mackinnon, S; Williams, R; (2003) Reversal of severe cholestasis caused by chronic graft-versus-host disease with the MARS liver-support device. TRANSPLANTATION , 75 (10) 1766 - 1767. 10.1097/01.TP.0000062538.32752.C1.

Shaw, B; Smith, C; Potter, M; Mayor, N; Marsh, SGE; Madrigal, JA; (2003) TNF Alpha promoter polymorphism may exhibit may exhibit recombination and have an impact on engraftment in unrelated donor HSCT. In: (pp. S51-).

Shaw, BE; Peggs, K; Bird, JM; Cavenagh, J; Hunter, A; Alejandro Madrigal, J; Russell, NH; ... Clinical Trials Committee of the British Society of Blood and Ma, ; + view all (2003) The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. Br J Haematol , 123 (5) pp. 886-895. 10.1046/j.1365-2141.2003.04714.x.

Shaw, BE; Peggs, K; Bird, JM; Cavenagh, J; Hunter, A; Madrigal, JA; Russell, NH; ... Marks, DI; + view all (2003) The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. BRIT J HAEMATOL , 123 (5) 886 - 895.

Shaw, BE; Potter, MN; Mayor, NP; Pay, AL; Smith, C; Goldman, JM; Prentice, HG; ... Madrigal, JA; + view all (2003) The degree of matching at HLA-DPB1 predicts for acute graft- versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplantation , 31 (11) pp. 1001-1008.

Shaw, BE; Potter, MN; Mayor, NP; Pay, AL; Smith, C; Goldman, JM; Prentice, HG; ... Madrigal, JA; + view all (2003) The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. BONE MARROW TRANSPL , 31 (11) 1001 - 1008. 10.1038/sj.bmt.1704029.

Shaw, BE; Potter, MN; Mayor, NP; Pay, AL; Smith, C; Goldman, JM; Prentice, HG; ... Madrigal, JA; + view all (2003) The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplantation , 31 (11) pp. 1001-1008. 10.1038/sj.bmt.1704029.

Shaw, BE; Smith, C; Potter, M; Mayor, N; Marsh, S; Madrigal, J; (2003) TNF alpha promoter polymorphisms may exhibit recombination and have an impact on engraftment in unrelated donor HSCT. In: GENES AND IMMUNITY. (pp. S51 - S51). NATURE PUBLISHING GROUP

Shaw, BE; Smith, C; Potter, MN; Mayor, NP; Marsh, SGE; Madrigal, JA; (2003) TNF alpha promoter polymorphisms have a significant impact on engraftment in unrelated donor hematopoietic stem cell transplant. In: BONE MARROW TRANSPLANTATION. (pp. S60 - S60). NATURE PUBLISHING GROUP

Shaw, BE; Towlson, K; Bird, JM; Madrigal, JA; Cavenagh, J; Marks, DI; British Soc BMT, ; (2003) Unrelated donor hematopoieitic stem cell transplantation for multiple myeloma: a retrospective study by the Clinical Trials Committee of the British Society of BMT and the Anthony Nolan Trust. In: BONE MARROW TRANSPLANTATION. (pp. S149 - S149). NATURE PUBLISHING GROUP

Simon, M; Grandage, VL; Linch, DC; Khwaja, A; (2003) Constitutive activation of the Wnt/beta-catenin pathway impairs myelomonocytic differentiation of normal progenitors and is found in acute myeloid leukaemia. In: BLOOD. (pp. 589A - 590A). AMER SOC HEMATOLOGY

Sinclair, PB; Sorour, A; Martineau, M; Harrison, CJ; Mitchell, W; O'Neill, E; Foroni, L; (2003) A comparative map of 6q deletions in ALL: Identification and analysis of GluR-6 as a candidate tumour suppressor gene. BLOOD , 102 (11) 4518-.

Smith, L; Lowdell, MW; (2003) Quality issues in stem cell and immunotherapy laboratories. TRANSFUSION MED , 13 (6) 417 - 423.

Somervaille, TCP; Linch, DC; Khwaja, A; (2003) Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitors. BRIT J HAEMATOL , 120 (5) 876 - 886.

Somervaille, TCP; Linch, DC; Khwaja, A; (2003) Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitors. British Journal of Haematology , 120 (5) pp. 876-886. 10.1046/j.1365-2141.2003.04204.x.

Starke, R; Harrison, P; Drummond, O; Macgregor, I; Mackie, I; Machin, S; (2003) The majority of cellular prion protein released from endothelial cells is soluble. TRANSFUSION , 43 (5) 677 - 678.

Starke, R; Harrison, P; Drummond, O; Macgregor, I; Mackie, I; Machin, S; Simak, J; ... Vostal, JG; + view all (2003) The majority of cellular prion protein released from endothelial cells is soluble [1] (multiple letters). Transfusion , 43 (5) pp. 677-678. 10.1046/j.1537-2995.2003.00405.x.

Starke, R; Harrison, P; Gale, R; Mackie, I; Drummond, O; MacGregor, I; Machin, S; (2003) Endothelial cells express normal cellular prion protein. BRIT J HAEMATOL , 123 (2) 372 - 373.

T

Tatton, L; Morley, GM; Chopra, R; Khwaja, A; (2003) The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. J BIOL CHEM , 278 (7) 4847 - 4853. 10.1074/jbc.M209321200. Gold open access

Tauro, S; Craddock, C; Peggs, K; Begum, G; Chopra, R; Littlewood, T; Parker, A; ... Mackinnon, S; + view all (2003) Allogeneic stem cell transplantation using a campath-1H based reduced-intensity-conditioning regimen improves survival in adults with high risk acute myeloid leukaemia and myelodysplasia. In: BLOOD. (pp. 463A - 464A). AMER SOC HEMATOLOGY

Thomson, K; Hart, D; Cook, G; Milligan, D; Parker, A; Marsh, J; Chopra, R; ... Mackinnon, S; + view all (2003) Lowering the dose of in vivo alemtuzumab (Campath-1H) in reduced intensity conditioning for allogeneic transplantation results in more graft-versus-host disease. In: BLOOD. (pp. 712A - 713A). AMER SOC HEMATOLOGY

Turner, MR; Warren, JD; Jacobs, JM; Groves, MJ; Yong, K; Honan, WP; Thomas, PK; (2003) Microvasculitic paraproteinaemic polyneuropathy and B-cell lymphoma. J PERIPHER NERV SYST , 8 (2) 100 - 107.

W

Watts, MJ; Ings, SJ; Balsa, C; Ahmed, F; Scott, M; Richardson, K; Linch, DC; (2003) Storage of PBSC in liquid phase for 16 hours leads to occult progenitor cell damage only fully apparent after freeze thawing. In: BLOOD. (pp. 40A - 40A). AMER SOC HEMATOLOGY

Whiteway, A; Corbett, T; Anderson, R; Macdonald, I; Prentice, HG; (2003) Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission. British Journal of Haematology , 120 (3) pp. 442-451.

Whiteway, A; Deru, W; Prentice, HG; Anderson, R; (2003) Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions. JOURNAL OF VIROLOGICAL METHODS , 114 (1) pp. 1-10. 10.1016/j.jviromet.2003.08.001.

Wilbourn, B; Harrison, P; Mackie, IJ; Liesner, R; Machin, SJ; (2003) Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism. BRIT J HAEMATOL , 122 (4) 651 - 661.

Wilbourn, B; Harrison, P; Mackie, IJ; Liesner, R; Machin, SJ; (2003) Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism. British Journal of Haematology , 122 (4) pp. 651-661. 10.1046/j.1365-2141.2003.04461.x.

Williams, E; Gardiner, C; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Preliminary data from the Medical Devices Agency (MDA) study of the CoaguCheck S in a patient self-testing environment. Br J Haematol , 121 (Suppl 1) p. 7.

Y

Yarranton, H; Cohen, H; Machin, SJ; (2003) Venous thromboembolism (VTE) associated withthe management of acute thrombotic thrombocytopenic purpura (TTP). In: (Proceedings) International society of thrombosis and haemostasis.

Yarranton, H; Cohen, H; Pavord, SR; Benjamin, S; Hagger, D; Machin, SJ; (2003) Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. BRIT J HAEMATOL , 121 (5) 778 - 785.

Yarranton, H; Lawrie, AS; Mackie, IJ; Machin, SJ; Pinkoski, L; Corash, L; (2003) Coagulation factor levels in cryosupernatant treated with amotosalen hydrochloride (S-59) and UVA light - a suitable plasma replacement in thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 817A - 817A). AMER SOC HEMATOLOGY

Z

Zhang, B; Cunningham, MA; Nichols, WC; Bernat, JA; Seligsohn, U; Pipe, SW; McVey, JH; ... Ginsburg, D; + view all (2003) Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet , 34 (2) pp. 220-225. 10.1038/ng1153.

This list was generated on Sun Aug 18 05:05:32 2019 BST.